Precision medicine starts here

Blue Latitude Health|18th May 2018

Precision medicine is set to revolutionise the healthcare sector, promising vastly improved outcomes for patients. However, as treatments become more precise, pharma companies will need to create more targeted commercial strategies. Meanwhile, the clinical trial recruitment process will become more challenging and a new series of stakeholders will emerge. These are just some of the barriers.

That’s why have dedicated the latest edition of our ‘Perspective’ magazine to this complex topic. We have combined the views of our in-house precision medicine experts and voices from key industry leaders to give you the latest information on the trend set to redefine healthcare as we know it – precision medicine.

In this edition of ‘Perspective’, we answer the following questions:

  • Are we ready for precision medicine?
  • How can you master the precision medicine opportunity?
  • How can industry drive greater engagement in the clinical trial recruitment process?
  • Will precision medicine change the way we interact with patients?
  • Who are the new healthcare influencers?

How Medisafe is using AI to improve patient adherence

Dina Patel|14th February 2019

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.

read more

Downloadable Pack: Understanding Multiple Sclerosis

Blue Latitude Health, Guest Blogger|6th February 2019

Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.

read more

Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy

Guest Blogger|1st February 2019

MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.

read more